ArchivePicks

MarKE CS2 player props

support · Voca · vs IS · Nov 15

MarKE (support, Voca) next faces Iowa Stormboar on 2026-11-15. On Kills (Maps 1+2), the posted line is 29.5; across the last 10 games the player was over in 6 of 10.

On Kills (Maps 1+2) (posted line 29.5), MarKE cleared it in 4 of 5 (80%) over the last 5 games played, 6 of 10 (60%) over the last 10, 12 of 17 (71%) this season. The average over those last 5 is 32.8, above the line. On Headshots (Maps 1+2) (posted line 16.5), MarKE cleared it in 4 of 5 (80%) over the last 5 games played, 5 of 10 (50%) over the last 10, 7 of 13 (54%) this season. The average over those last 5 is 20.8, above the line. Across 2 posted markets, the highest last-10 hit rate is Kills (Maps 1+2) at 60%.

Next game: Iowa Stormboar at Voca player props.

Posted lines for MarKE with how often the player has cleared each number over the last 5 games, last 10 games and this season. Open a market for the full game log, head-to-head history and a line you can move.

MarketLineOver / UnderL5L10SeasonOpponent defense
Kills (Maps 1+2)29.5-115 / -115 (Underdog Pick'em)80%60%71%—
Headshots (Maps 1+2)16.5-115 / -115 (Underdog Pick'em)80%50%54%—

Kills (Maps 1+2): recent games

Over in 6 of 10 at a line of 29.5.

DateOppResultvs line
Sep 9vs VILLAINO20Under
Sep 10vs NRG26Under
Sep 11@ ANTIVALU33Over
Sep 11vs WAR32Over
Sep 12vs LIQUID22Under
Sep 25@ DENDELE39Over
Sep 25@ BESTIA32Over
Sep 26@ M8034Over
Oct 2vs 1T32Over
Nov 14vs NUTORIOU27Under

Headshots (Maps 1+2): recent games

Over in 5 of 10 at a line of 16.5.

DateOppResultvs line
Sep 9vs VILLAINO13Under
Sep 10vs NRG15Under
Sep 11@ ANTIVALU20Over
Sep 11vs WAR6Under
Sep 12vs LIQUID15Under
Sep 25@ DENDELE27Over
Sep 25@ BESTIA21Over
Sep 26@ M8018Over
Oct 2vs 1T22Over
Nov 14vs NUTORIOU16Under

Hit rates describe past games; they are not a forecast. ArchivePicks does not take bets and does not tell you which side to take. See the methodology.

Keep researching

Related players

For information only. Gambling problem? Call 1-800-GAMBLER.